New Zealand Hemostatic Agents Market - Forecast(2024 - 2030)

Report Code: HCR 1333 Report Format: PDF + Excel
1. New Zealand Hemostatic Agents Market – Overview
2. New Zealand Hemostatic Agents Market – Executive Summary 
3. New Zealand Hemostatic Agents Market Landscape
3.1.  Market Share Analysis
3.2.  Comparative Analysis
3.2.1. Product Benchmarking
3.2.2. End User Profiling
3.2.3. Financials Analysis
4. New Zealand Hemostatic Agents Market Forces
4.1. Drivers
4.2. Restraints & Challenges
4.3. Porter’s Five Forces Analysis
4.3.1. Bargaining Power of Suppliers
4.3.2. Bargaining Power of Buyers
4.3.3. Threat of New Entrants
4.3.4. Threat of Substitutes
4.3.5. Degree of Competition
5. New Zealand Hemostatic Agents Market – Strategic Analysis
5.1. Value Chain Analysis
5.2. Opportunities Analysis
6. New Zealand Hemostatic Agents Market– Export Analysis of Hemostatic Agents
7. New Zealand Hemostatic Agents Market– By Type
7.1. Introduction
7.2. Passive Hemostatic Agents
7.2.1. Collagen
7.2.1.1. Bovine Collagen
7.2.1.2. Microfibrillar Collagen
7.2.2. Cellulose
7.2.2.1. Resorbable Oxidized Cellulose
7.2.2.2. Regenerated Cotton Cellulose
7.2.3. Gelatins
7.2.4. Chitosan
7.3. Combination Hemostats
7.4. Topical Hemostatic Agents
7.4.1. Physical agents 
7.4.1.1. Bone wax
7.4.1.2. Ostene
7.4.2. Absorbable agents
7.4.2.1. Gelatin foams
7.4.2.2. Oxidized cellulose
7.4.2.3. Microfibrillar collagen
7.4.3. Biologic agents 
7.4.3.1. Thrombin
7.4.3.2. Fibrin sealants
7.4.3.3. Platelet gel
7.4.4. Synthetic agents 
7.4.4.1. Polyethylene glycol hydrogels
7.4.4.2. Cyanoacrylates
7.4.4.3. Glutaraldehyde cross-linked albumin
7.5.  Others 
8. New Zealand Hemostatic Agents Market – By Treatment
8.1. Introduction
8.2. Cardiovascular
8.3. General Surgery 
8.4. Digestive Surgery 
8.5. Neurosurgery 
8.6. Trauma
8.7. Transplant
8.8. Oncology
8.9. Dental
8.10. Others (Urological Surgeries, Pulmonary Surgeries)
9. New Zealand Hemostatic Agents Market – By End Users
9.1. Introduction
9.2. Hospitals
9.3. Ambulatory Surgery Centres 
9.4. Nursing Homes
9.5. Others
10. New Zealand Hemostatic Agents Market Entropy
11. New Zealand Hemostatic Agents Market Company Profiles 
11.1. Company 1
11.2. Company 2
11.3. Company 3
11.4. Company 4
11.5. Company 5
11.6. Company 6
11.7. Company 7
11.8. Company 8
11.9. Company 9
11.11. Company 11 and more
*Financials would be provided on a best efforts basis for private companies"
12. Appendix
12.1. Abbreviations
12.2. Sources
12.3. Research Methodology
12.4. Bibliography
12.5. Compilation of Expert Insights
12.6. Disclaimer